KX-01

Unassigned

New Medicines

Actinic keratosis

Information

New molecular entity
Almirall
Almirall

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

A small molecule, non-ATP competitive Src kinase inhibitor
AK occurs most often in individuals with fair skin, blonde hair and blue eyes at a rate according to cumulative UV exposure. In the UK, prevalence has been reported to be around 19-24% of the population over the age of 60 years [1].
Actinic keratosis
Topical